Daily ReportAug 31, 2026
Anesthesiology, August 31 edition
We read 17 papers and selected 3.
Summary
Today’s strongest studies addressed mechanistic heterogeneity in anesthetic emergence, perioperative hemodynamic instability during hepatic chemosaturation, and targeted regional analgesia for outpatient hysteroscopy. The most conceptually important finding was that ventral tegmental area dopamine neurons promote emergence in an agent-specific manner, while the clinical studies identified actionable approaches to vasopressor management and procedural pain control.
Research Themes
- Agent-specific neural mechanisms of emergence from anesthesia
- Catecholamine pharmacokinetics and hemodynamic instability during extracorporeal hepatic chemosaturation
- Anatomically targeted regional anesthesia for ambulatory procedural pain
Selected Articles
1. The role of ventral tegmental area dopamine neurons in emergence from dexmedetomidine, fentanyl, and ketamine anesthesia in rats.
In rats, optogenetic stimulation of tyrosine hydroxylase-positive ventral tegmental area dopamine neurons reliably promoted righting during dexmedetomidine-induced unconsciousness and reduced low-frequency electroencephalographic power in responders. The same stimulation did not improve fentanyl emergence and modestly delayed emergence from ketamine, demonstrating that dopamine-mediated arousal is agent-specific rather than a universal reversal pathway.
Impact: This study challenges the assumption that a single arousal circuit can reverse unconsciousness produced by mechanistically diverse anesthetics. Its bidirectional, agent-dependent results provide a mechanistic framework for developing more precise strategies to accelerate emergence and explain why an intervention may work for one anesthetic but fail for another.
Clinical Implications: The findings do not yet support clinical manipulation of ventral tegmental area dopamine neurons, but they suggest that pharmacologic or neuromodulatory emergence interventions should be tailored to the anesthetic agent and its dominant neural targets. They also caution against assuming that a reversal strategy effective for dexmedetomidine will be effective for opioids or ketamine.
Key Findings
- Optogenetic stimulation restored righting during dexmedetomidine-induced unconsciousness with a hazard ratio of 27.7.
- Responders to dexmedetomidine stimulation showed attenuated low-frequency EEG power below 12 Hz.
- The intervention did not affect fentanyl emergence and modestly delayed emergence from ketamine.
Methodological Strengths
- Selective viral targeting of tyrosine hydroxylase-positive ventral tegmental area neurons was functionally validated during sevoflurane anesthesia.
- A randomized block design combined behavioral righting measures with frontal electroencephalography and mixed-effects time-to-event analysis.
Limitations
- The experiments were performed in adult rats, so translation to human anesthetic emergence is uncertain.
- The study tested selected drug-induced unconscious states and did not establish the full circuit mechanisms underlying the agent-specific effects.
Future Directions: Future work should map downstream and parallel arousal circuits for each anesthetic, test pharmacologic modulation of these pathways, and determine whether agent-specific signatures can predict or guide emergence in humans.
BACKGROUND: Dopamine neurons in the ventral tegmental area (VTA), a midbrain structure, have been widely implicated in promoting emergence from general anesthesia. However, most studies have focused on anesthetics that primarily target GABAA receptors. Whether these neurons also facilitate emergence from mechanistically diverse drug-induced unconscious states is not known. Here we examine the specific contribution of VTA dopamine neurons in restoring arousal following sevoflurane-, dexmedetomidine-, fentanyl-, and ketamine-induced unconsciousness. METHODS: Adult Sprague Dawley rats received viral constructs driving selective expression in tyrosine hydroxylase-positive VTA neurons of either channelrhodopsin or the control protein, YFP.
2. King's Mill anterior-posterior and transverse versus paracervical block in operative outpatient hysteroscopy: a randomised trial.
In a participant- and outcome-assessor-blinded randomized trial of 48 women undergoing operative outpatient hysteroscopy, the anatomically targeted KAPT block produced lower median pain during the procedure and 10 minutes afterward than the conventional paracervical block. Both co-primary endpoints were significant under hierarchical testing, with no serious adverse events, supporting larger multicenter evaluation.
Impact: The trial evaluates a novel block designed around the distribution of uterine and cervical sensory fibers rather than the conventional injection site. Its blinded randomized design and clinically meaningful reduction in pain provide a practical pathway to improve completion and tolerability of outpatient hysteroscopy.
Clinical Implications: The KAPT block may be considered a promising alternative to the paracervical block for awake operative outpatient hysteroscopy, particularly when pain limits procedural tolerance. Before routine adoption, clinicians should confirm training requirements, safety, reproducibility, and effectiveness in larger and more diverse populations.
Key Findings
- Median intra-procedural pain was 1 with KAPT versus 2 with paracervical block, with P = 0.040.
- Pain 10 minutes after the procedure was 0 with KAPT versus 2 with paracervical block, with P = 0.011.
- Both co-primary endpoints were significant under hierarchical testing, and no serious adverse events occurred.
Methodological Strengths
- Participant and outcome-assessor blinding, 1:1 randomization, and intention-to-treat analysis reduced major performance and assessment biases.
- The study used co-primary endpoints with hierarchical fixed-sequence testing and reported effect estimates with confidence intervals.
Limitations
- The single-center sample of 48 women was small and may provide imprecise estimates of treatment effect.
- The trial did not show a significant difference in cervical dilatation pain, and generalizability to other procedures, operators, and patient populations remains uncertain.
Future Directions: A multicenter adequately powered trial should assess procedure completion, rescue analgesia, patient experience, adverse events, operator learning curves, and cost-effectiveness across different hysteroscopic interventions.
BACKGROUND: Pain control during operative outpatient hysteroscopy remains a clinical challenge, with the paracervical block (PCB) showing inconsistent efficacy. The King's Mill Anterior-Posterior and Transverse (KAPT) block targets the Lee-Frankenhauser plexus within the uterosacral ligament complex, where the highest density of uterine and cervical sensory fibres lies. We compared the KAPT block with the PCB in operative outpatient hysteroscopy. METHODS: Single-centre, participant- and outcome assessor-blinded randomised controlled trial in a UK district general hospital. Forty-eight women undergoing operative outpatient hysteroscopy were randomised 1:1 to the KAPT block or the PCB, each delivered with 10 ml of prilocaine.
3. Activated charcoal filtration profoundly alters systemic noradrenaline concentrations during hepatic chemosaturation: A prospective cohort study.
During hepatic chemosaturation with extracorporeal circulation, systemic noradrenaline rose during caval occlusion and extracorporeal circulation, while activated charcoal filtration removed a median 95.5% of circulating noradrenaline despite continued high-dose administration. A rebound increase occurred after extracorporeal circulation ended, accompanied by metabolic acidosis and increasing lactate, identifying a pharmacokinetic mechanism that may contribute directly to perioperative hemodynamic instability.
Impact: This study identifies selective removal of noradrenaline by the charcoal filter as a previously underappreciated contributor to hemodynamic instability. The finding links extracorporeal circuit design to vasopressor pharmacology and offers an immediately testable basis for modifying vasopressor dosing and monitoring.
Clinical Implications: Anesthesiologists should anticipate substantial noradrenaline extraction during charcoal filtration, interpret vasopressor requirements in relation to circuit timing, and closely monitor for rebound catecholamine exposure after extracorporeal circulation. Protocols may need time-specific vasopressor adjustment and post-circuit surveillance of blood pressure, lactate, and metabolic status.
Key Findings
- Noradrenaline concentrations increased significantly during inferior vena cava occlusion and extracorporeal circulation.
- Activated charcoal filtration produced a median noradrenaline extraction rate of 95.5%.
- Noradrenaline rebounded after extracorporeal circulation termination, alongside metabolic acidosis and rising lactate.
Methodological Strengths
- Prospective sampling at predefined perioperative and filtration time points directly captured concentration changes across the circuit.
- The study was prospectively registered, and catecholamine concentrations were interpreted together with vasopressor dosing and metabolic indicators.
Limitations
- The cohort included only 15 procedures at a single center, limiting statistical precision and generalizability.
- The observational design cannot prove that noradrenaline extraction was the sole cause of hemodynamic instability, and there was no comparison with an alternative filtration strategy.
Future Directions: Multicenter studies should compare vasopressor protocols and filtration technologies, quantify clinical outcome effects, and test whether circuit modifications or alternative catecholamine strategies reduce instability and post-circuit rebound.
BACKGROUND: Hepatic chemosaturation using extracorporeal circulation (ECC) is associated with severe hemodynamic instability. Activated charcoal filters are used to prevent systemic toxicity, but their effects on circulating catecholamines remain poorly understood. METHODS: In this prospective, single-center observational study, systemic catecholamine concentrations were measured in 15 procedures undergoing hepatic chemosaturation. Blood samples were obtained at predefined time points: after induction of anesthesia (T0), during initiation of ECC (T1), immediately before (T2.1) and after charcoal filtration (T2.2) and after termination of ECC (T3). RESULTS: Systemic noradrenaline concentrations changed significantly over time (p < 0.001).